Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis

Journal of Neurology

Volumn 251, Issue 5, 2004, Pages 542-547

  Dong Si, T ^a   Weber, J ^a   Liu, Y B ^a   Buhmann, C ^b   Bauer, H ^c   Bendl, C ^a   Schnitzler, P ^a   Grond Ginsbach, C ^a   Grau, A J ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Cerebrospinal fluid; Chlamydia pneumoniae; Infection; Multiple sclerosis

Indexed keywords

BACTERIAL DNA; BACTERIAL PROTEIN; BACTERIAL RNA; HEAT SHOCK PROTEIN 60; MESSENGER RNA; RIBOSOME RNA;

ADULT; ARTICLE; CEREBROSPINAL FLUID EXAMINATION; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHUMAN; PATHOLOGY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLING;

ADULT; BACTERIAL OUTER MEMBRANE PROTEINS; BLOTTING, NORTHERN; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DNA, VIRAL; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NERVOUS SYSTEM DISEASES; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 2542425801     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-004-0360-0     Document Type: Article

References (32)

1. Airenne S, Surcel HM, Alakärppä H, et al. (1999) Chlamydia pneumoniae infection in human monocytes. Infect Immun 67:1445-1449
2. Apfalter P, Blasi F, Boman J, et al. (2001) Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens. J Clin Microbiol 39:519-524
3. Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, Penninger JM (1999) Chlamydia infections and heart disease linked through antigenic mimicry. Science 283:1335-1339
4. Boman J, Roblin PM, Sundström P, et al. (2000) Failure to detect C. pneumoniae in the central nervous system of patients with MS. Neurology 54:265
5. Brosnan CF, Battistini L, Gao YL, Raine CS, Aquino DA (1996) Heat shock proteins and multiple sclerosis. A review. J Neuropathol Exp Neurol 55:389-402
6. Casetta I, Granieri E (2000) Clinical infections and multiple sclerosis: contribution from analytical epidemiology. J Neurovirol 6(Suppl. 2):S147-S151
7. Chatzipanagiotou S, Tsakanigas C, Anagnostouli M, et al. (2003) Detection of Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis by combination of cell culture and PCR: no evidence for possible association. Mol Diagn 7:41-43
8. Derfuss T, Gürkov R, Then Bergh F, et al. (2001) Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response. Brain 124:1325-1335
9. Dowell SF, Peeling RW, Boman J, et al. (2001) Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 33:492-503
10. Gieffers J, Pohl D, Treib J, et al. (2001) Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis. Ann Neurol 49:585-589
11. Goverman J, Woods A, Larson L, et al. (1993) Transgenic mice that express a Melin Basic Protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72:551-560
12. Grayston JT (2000) Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 181(Suppl.3):S402-410
13. Grimaldi LM, Pincherle A, Martinelli-Boneschi F, et al. (2003) An MRI study of Chlamydia pneumoniae infection in Italian multiple sclerosis patients. Mult Scler 9:467-471
14. Hammerschlag MR, Ke Z, Lu F, et al. (2000) Is Chlamydia pneumoniae present in brain lesions of patients with multiple sclerosis? J Clin Microbiol 38:4274-4276
15. Haranaga S, Yamaguchi H, Leparc GF, et al. (2001) Detection of Chlamydia pneumoniae antigen in PBMNCs of healthy blood donors. Transfusion 41:1114-1119
16. Ho L, Javed AA, Pepin RA, et al. (1988) Identification of a cDNA clone for the β-subunit of the pyruvate dehydrogenase component of human pyruvate dehydrogenase complex. Biochem Biophys Res Commun 150:904-908
17. Ikejima H, Haranaga S, Takemura H, et al. (2001) PCR-based method for isolation and detection of Chlamydia pneumoniae DNA in cerebrospinal fluids. Clin Diagn Lab Immunol 8:499-502
18. Kaufman M, Gaydos CA, Sriram S, et al. (2002) Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results. Mult Scler 8:289-294
19. Kuoppa Y, Bomann J, Scott L, et al. (2002) Quantitative detection of respiratory Chlamydia pneumoniae infection by real-time PCR. J Clin Microbiol 40:2273-2274
20. Kurtzke JF (1993) Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 6:382-427
21. Krametter D, Niederwieser G, Berghold A, et al. (2001) Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker. Mult Scler 7:13-18
22. Layh-Schmitt G, Bendl C, Hildt U, et al. (2000) Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis. Ann Neurol 47:652-655
23. Lenz DC, Lu L, Conant SB, et al. (2001) A Chlamydia pneumoniae-specific peptide induces experimental autoimmune encephalomyelitis in rats. J Immunol 167:1803-1808
24. McDonald WI, Compston A, Edan G, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121-127
25. Numazaki K, Chibar S (2001) Failure to detect C. pneumoniae in the central nervous system of patients with MS. Neurology 57:746 (letter)
26. Prazeres da Costa C, Kirschning CJ, Busch D, et al. (2002) Role of chlamydial heat shock protein 60 in the stimulation of innate immune cells by Chlamydia pneumoniae. Eur J Immunol 32:2460-2470
27. Pucci E, Taus C, Cartechini E, et al. (2000) Lack of C. pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 48:399-400
28. Saiz A, Marcos MA, Graus F, et al. (2001) No evidence of CNS infection with C. pneumoniae in patients with multiple sclerosis. J Neurol 248:617-618
29. Sotgiu S, Piana A, Pugliatti M, et al. (2001) Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls. Mult Scler 7:371-374
30. Sriram S, Stratton CW, Yao SY, et al. (1999) Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 46:6-14
31. Tong CYW, Sillis M (1993) Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR. J Clin Pathol 46:313-317
32. Yao SY, Stratton CW, Mitchell WM, Sriram S (2001) CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens. Neurology 56:1168-1176